NO178056C - Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet - Google Patents

Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet

Info

Publication number: NO178056C
Authority: NO; Norway
Prior art keywords: tolerance; preparing; organic anions; pharmaceutical composition; retention rate
Prior art date: 1988-09-19

Application number

NO902132A

Other languages

English (en)

Norwegian (no)

Other versions

NO902132L (no

NO902132D0 (no

NO178056B (no

Inventor

Richard G Markham

Original Assignee

Oxycal Lab Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-09-19

Filing date

1990-05-14

Publication date

1996-01-17

1988-09-19 Priority claimed from US07/246,504 external-priority patent/US4968716A/en

1989-04-07 Priority claimed from PCT/US1989/001642 external-priority patent/WO1990012571A1/en

1990-05-14 Application filed by Oxycal Lab Inc filed Critical Oxycal Lab Inc

1990-05-14 Publication of NO902132L publication Critical patent/NO902132L/no

1990-05-14 Publication of NO902132D0 publication Critical patent/NO902132D0/no

1994-12-21 Priority to NO19944971A priority Critical patent/NO311219B1/no

1995-10-09 Publication of NO178056B publication Critical patent/NO178056B/no

1996-01-17 Publication of NO178056C publication Critical patent/NO178056C/no

Links

238000000034 method Methods 0.000 title abstract 4
238000010521 absorption reaction Methods 0.000 title abstract 2
230000014759 maintenance of location Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
150000002891 organic anions Chemical class 0.000 abstract 3
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 abstract 2
229930003268 Vitamin C Natural products 0.000 abstract 2
235000019154 vitamin C Nutrition 0.000 abstract 2
239000011718 vitamin C Substances 0.000 abstract 2
QXKAIJAYHKCRRA-PZGQECOJSA-N L-lyxonic acid Chemical class OC[C@H](O)[C@@H](O)[C@@H](O)C(O)=O QXKAIJAYHKCRRA-PZGQECOJSA-N 0.000 abstract 1
230000029142 excretion Effects 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
230000037361 pathway Effects 0.000 abstract 1
230000007756 renal tubular secretion Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Epidemiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Nutrition Science (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO902132A 1988-09-19 1990-05-14 Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet NO178056C (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO19944971A NO311219B1 (no)	1988-09-19	1994-12-21	Fremgangsmåte for fremstilling av et preparat med forbedret vitamin C-aktivitet

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US07/246,504 US4968716A (en)	1987-04-10	1988-09-19	Compositions and methods for administering therapeutically active compounds
PCT/US1989/001642 WO1990012571A1 (en)	1989-04-07	1989-04-07	Compositions and methods for administering vitamin c
PCT/US1989/004046 WO1990003167A1 (en)	1988-09-19	1989-09-15	Compositions and methods for administering therapeutically active compounds

Publications (4)

Publication Number	Publication Date
NO902132L NO902132L (no)	1990-05-14
NO902132D0 NO902132D0 (no)	1990-05-14
NO178056B NO178056B (no)	1995-10-09
NO178056C true NO178056C (no)	1996-01-17

Family

ID=22930954

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO902132A NO178056C (no)	1988-09-19	1990-05-14	Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet

Country Status (16)

Country	Link
EP (1)	EP0417209B1 (de)
JP (1)	JP2973365B2 (de)
AT (1)	ATE160939T1 (de)
CA (1)	CA1341434C (de)
DE (1)	DE68928488T2 (de)
DK (1)	DK175783B1 (de)
FI (1)	FI97950C (de)
HU (1)	HU905911D0 (de)
NO (1)	NO178056C (de)
NZ (1)	NZ230700A (de)
PL (1)	PL165416B1 (de)
RO (1)	RO108148B1 (de)
RU (1)	RU2059410C1 (de)
WO (1)	WO1990003167A1 (de)
YU (1)	YU47746B (de)
ZA (1)	ZA904494B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU783283B2 (en) *	1999-08-30	2005-10-13	Ester C Company, The	Methods and compositions for selective cancer chemotherapy
HUP0600084A2 (en) *	2001-08-24	2006-06-28	Rath	Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
AT501682A1 (de)	2005-01-14	2006-10-15	Hermine Dr Engl	Verfahren zur herstellung einer wirkstoffmischung
FI20095278A0 (fi)	2009-03-18	2009-03-18	Valtion Teknillinen	Ksylonihapon valmistus
KR101037125B1 (ko) *	2009-05-14	2011-05-26	계명대학교 산학협력단	바이오에탄올 생산을 위한 바이오매스 전처리법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2606903A (en) *	1944-03-29	1952-08-12	Physiological Chemicals Compan	Ascorbic acid addition compound of sulfathiazole
US2822317A (en) *	1955-12-12	1958-02-04	Smith Kline French Lab	Aqueous iron-ascorbic acid preparation
GB2040164A (en) *	1979-01-31	1980-08-28	Beecham Group Ltd	Compositions containing paracetamol
US4822816A (en) *	1987-04-10	1989-04-18	Oxycal Laboratories, Inc.	Compositions and methods for administering vitamin C

1989
- 1989-09-15 AT AT89910989T patent/ATE160939T1/de not_active IP Right Cessation
- 1989-09-15 WO PCT/US1989/004046 patent/WO1990003167A1/en not_active Ceased
- 1989-09-15 RU SU4830452/14A patent/RU2059410C1/ru active
- 1989-09-15 EP EP89910989A patent/EP0417209B1/de not_active Expired - Lifetime
- 1989-09-15 JP JP1510161A patent/JP2973365B2/ja not_active Expired - Lifetime
- 1989-09-15 RO RO145105A patent/RO108148B1/ro unknown
- 1989-09-15 DE DE68928488T patent/DE68928488T2/de not_active Expired - Lifetime
- 1989-09-18 CA CA000611779A patent/CA1341434C/en not_active Expired - Lifetime
- 1989-09-19 NZ NZ230700A patent/NZ230700A/en unknown
1990
- 1990-05-14 NO NO902132A patent/NO178056C/no not_active IP Right Cessation
- 1990-05-18 FI FI902461A patent/FI97950C/fi active IP Right Grant
- 1990-05-18 DK DK199001242A patent/DK175783B1/da not_active IP Right Cessation
- 1990-06-11 ZA ZA904494A patent/ZA904494B/xx unknown
- 1990-06-15 YU YU117890A patent/YU47746B/sh unknown
- 1990-09-14 PL PL90286897A patent/PL165416B1/pl unknown
- 1990-09-14 HU HU905911A patent/HU905911D0/hu unknown

Also Published As

Publication number	Publication date
DK124290A (da)	1990-05-18
ZA904494B (en)	1991-03-27
DE68928488T2 (de)	1998-04-02
AU621672B2 (en)	1992-03-19
WO1990003167A1 (en)	1990-04-05
RU2059410C1 (ru)	1996-05-10
ATE160939T1 (de)	1997-12-15
HU905911D0 (en)	1991-03-28
FI97950B (fi)	1996-12-13
PL165416B1 (pl)	1994-12-30
EP0417209A4 (en)	1992-01-08
CA1341434C (en)	2003-07-08
YU117890A (sh)	1993-10-20
NO902132L (no)	1990-05-14
EP0417209B1 (de)	1997-12-10
AU4328889A (en)	1990-04-18
FI902461A0 (fi)	1990-05-18
JP2973365B2 (ja)	1999-11-08
RO108148B1 (ro)	1994-02-28
EP0417209A1 (de)	1991-03-20
DE68928488D1 (de)	1998-01-22
DK175783B1 (da)	2005-02-21
DK124290D0 (da)	1990-05-18
JPH03504502A (ja)	1991-10-03
NZ230700A (en)	1992-07-28
NO902132D0 (no)	1990-05-14
YU47746B (sh)	1996-01-08
NO178056B (no)	1995-10-09
FI97950C (fi)	1997-03-25

Similar Documents

Publication	Publication Date	Title
AU4312285A (en)	1985-12-05	Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
SE8402549D0 (sv)	1984-05-11	Substituerade moranolinderivat
IE780643L (en)	1978-10-29	THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
NO893270D0 (no)	1989-08-15	Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
AU8091787A (en)	1988-05-12	The use of paroxetine to treat pain
DK0668077T3 (da)	2001-10-08	Produkter, som indeholder G-CSF og TNF-bindende protein
ZA893086B (en)	1990-12-28	4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial disease
IE780503L (en)	1978-09-17	Pyridinyl aminoalkyl ethers.
JPS56106594A (en)	1981-08-24	Stabilizing method of plasminogen
ZA904494B (en)	1991-03-27	Compositions and methods for administering therapeutically active compounds
ATE116849T1 (de)	1995-01-15	Pharmazeutische verwendung von fettsäuren.
RU2001118854A (ru)	2003-11-20	Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
EP0381181A3 (de)	1991-09-18	System zur gesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu dessen Herstellung
IE44339L (en)	1977-08-07	Piperazine derivatives.
CA1215323A (en)	1986-12-16	Curative composition for buerger's disease
NO893256L (no)	1990-02-16	Fremgangsmaate for fremstilling av furyltiazolderivater.
DK15088D0 (da)	1988-01-13	Antibakterielt lyofiliseret praeparat
HUT54039A (en)	1991-01-28	Process for producing galenic compositions ensuring optimal biological accessibility of 2-hydroxy-5-methyllaurophenoneoxime active ingredient
EP0272057A3 (de)	1989-01-11	Pyranochinoline enthaltende pharmazeutische Zusammensetzungen
RU98111356A (ru)	2000-04-10	Способ лечения ожогового шока
HUT50438A (en)	1990-02-28	Process for production of medical compositions containing as active substance 2-/2-methil-4-chlor-phenilimin/-imidasolidine
KR900701265A (ko)	1990-12-01	치료활성제(Therapeutically active compounds) 투여에 관한 방법과 그에 대한 조성물
IT1233503B (it)	1992-04-03	Vinpocetina per emorragia polmonare e per edema polmonare
RU92016264A (ru)	1995-05-20	Новые соединения, способ их получения, фармацевтический состав, его получение, способ профилактики или лечения, применение соединений
IE38235L (en)	1974-03-15	Combatting swine dysentery

Legal Events

Date	Code	Title	Description
2009-10-05	MK1K	Patent expired